Please use this identifier to cite or link to this item:
http://ir.mu.ac.ke:8080/jspui/handle/123456789/9584Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cheruiyot, Stanley | - |
| dc.contributor.author | Kimathi, Derick | - |
| dc.contributor.author | Ndeye, BobS. | - |
| dc.date.accessioned | 2025-02-26T12:19:28Z | - |
| dc.date.available | 2025-02-26T12:19:28Z | - |
| dc.date.issued | 2025-02 | - |
| dc.identifier.uri | http://ir.mu.ac.ke:8080/jspui/handle/123456789/9584 | - |
| dc.description.abstract | Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain unknown. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | The New Journal of England Medicine | en_US |
| dc.subject | Yellow fever | en_US |
| dc.subject | Vaccine | en_US |
| dc.title | Low-Dose Yellow Fever Vaccine in Adults in Africa | en_US |
| dc.title.alternative | Ph.D., Benedict Orindi, Ph.D., Maria L. Namulwana, M.B., Ch.B., Antoine Diatta, Pharm.D., t, B.Sc. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | School of Medicine | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| nejmoa2407293.pptx | 1.95 MB | Microsoft Powerpoint XML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.